FIELD: biotechnology.
SUBSTANCE: anti-Siglec-9 antibody molecules or its anti-Siglec-9 binding fragment are disclosed.
EFFECT: invention can find further application in treating cancer, acute or chronic hepatitis B.
6 cl, 9 dwg, 6 tbl, 9 ex
| Title |
Year |
Author |
Number |
| ANTIBODIES AGAINST SIGLEC-15 AND THEIR APPLICATION METHODS |
2017 |
- Liu, Linda
- Flies, Dallas, Benjamin
- Langermann, Solomon
|
RU2759334C2 |
| ANTI-BK VIRUS ANTIBODY MOLECULES |
2021 |
- Weber, Marcel
- Schmitt, Simone
- Esslinger, Christoph
- Schachtner, Thomas
- Huynh-Do, Uyen
- Provenzano, Maurizio
|
RU2835801C1 |
| POLYPEPTIDES MODULATING SIGLEC-DEPENDENT IMMUNE RESPONSES |
2017 |
- Kannicht, Christoph
- Winge, Stefan
- Kohla, Guido
- Solecka-Witulska, Barbara
|
RU2776807C2 |
| SARS-CoV-2 ANTIBODIES AND METHODS OF USE THEREOF |
2021 |
- Corti Davide
- Fink Katja
- Beltramello Martina
- Cameroni Elisabetta
- Pinto Dora
- Snell Gyorgy
- Lempp Florian A.
- Telenti Amalio
|
RU2832025C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING AN ANTIBODY SPECIFICALLY BINDING WITH THE N-TERMINAL OF LYSYL-TRNA SYNTHETASE AS AN EFFECTIVE INGREDIENT FOR THE PREVENTION OR TREATMENT OF DISEASES CAUSED BY CELL MIGRATION |
2018 |
- Kwon Nam Hoon
- Lee Jin Young
- Kim Sunghoon
|
RU2749591C1 |
| ANTIBODY FOR SPECIFIC BINDING TO N-TERMINAL DOMAIN OF LYSYL-TRNA SYNTHETASE EXPOSED ON EXTRACELLULAR MEMBRANE |
2019 |
- Kim Sunghoon
- Kwon Nam Hoon
|
RU2781304C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF MALIGNANT TUMOR |
2017 |
- Okano, Fumiesi
- Saito, Takanori
|
RU2766586C2 |
| ANTIBODY SPECIFICALLY BINDING TO N-TERMINAL REGION OF LYSYL-TRNA-SYNTHETASE EXPOSED ON CELL MEMBRANE |
2018 |
- Kim Sunghoon
- Shim Hyun Bo
- Kwon Nam Hoon
- Han Dae Young
|
RU2739393C1 |
| ANTIBODIES B7-H4 AND METHODS FOR THEIR APPLICATION |
2019 |
- Langermann, Solomon
- Flies, Dallas, Benjamin
- Liu, Linda
|
RU2809243C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF MALIGNANT TUMOR |
2019 |
- Okano, Fumiyoshi
- Saito, Takanori
|
RU2781542C2 |
